Literature DB >> 16612405

Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia.

Clemens Grabher1, Harald von Boehmer, A Thomas Look.   

Abstract

The chromosomal translocation t(7;9) in human T-cell acute lymphoblastic leukaemia (T-ALL) results in deregulated expression of a truncated, activated form of Notch 1 (TAN1) under the control of the T-cell receptor-beta (TCRB) locus. Although TAN1 efficiently induces T-ALL in mouse models, t(7;9) is present in less than 1% of human T-ALL cases. The recent discovery of novel activating mutations in NOTCH1 in more than 50% of human T-ALL samples has made it clear that Notch 1 is far more important in human T-ALL pathogenesis than previously suspected.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16612405     DOI: 10.1038/nrc1880

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  177 in total

Review 1.  Notch in the kidney: development and disease.

Authors:  Yasemin Sirin; Katalin Susztak
Journal:  J Pathol       Date:  2011-08-24       Impact factor: 7.996

2.  Gamma secretase inhibitors enhance vincristine-induced apoptosis in T-ALL in a NOTCH-independent manner.

Authors:  Sun-Ok Yoon; Mariana C Zapata; Akannsha Singh; Wol Soon Jo; Nakia Spencer; Yong Sung Choi
Journal:  Apoptosis       Date:  2014-11       Impact factor: 4.677

3.  Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia.

Authors:  Teresa Palomero; Maria Luisa Sulis; Maria Cortina; Pedro J Real; Kelly Barnes; Maria Ciofani; Esther Caparros; Jean Buteau; Kristy Brown; Sherrie L Perkins; Govind Bhagat; Archana M Agarwal; Giuseppe Basso; Mireia Castillo; Satoru Nagase; Carlos Cordon-Cardo; Ramon Parsons; Juan Carlos Zúñiga-Pflücker; Maria Dominguez; Adolfo A Ferrando
Journal:  Nat Med       Date:  2007-09-16       Impact factor: 53.440

4.  Interconnecting molecular pathways in the pathogenesis and drug sensitivity of T-cell acute lymphoblastic leukemia.

Authors:  Takaomi Sanda; Xiaoyu Li; Alejandro Gutierrez; Yebin Ahn; Donna S Neuberg; Jennifer O'Neil; Peter R Strack; Christopher G Winter; Stuart S Winter; Richard S Larson; Harald von Boehmer; A Thomas Look
Journal:  Blood       Date:  2009-12-09       Impact factor: 22.113

5.  Acute T-cell leukemias remain dependent on Notch signaling despite PTEN and INK4A/ARF loss.

Authors:  Hind Medyouf; Xiuhua Gao; Florence Armstrong; Samuel Gusscott; Qing Liu; Amanda Larson Gedman; Larry H Matherly; Kirk R Schultz; Francoise Pflumio; Mingjian James You; Andrew P Weng
Journal:  Blood       Date:  2009-12-11       Impact factor: 22.113

Review 6.  The pathogenic role of Notch activation in podocytes.

Authors:  Thiruvur Niranjan; Mariana Murea; Katalin Susztak
Journal:  Nephron Exp Nephrol       Date:  2009-03-17

7.  High mobility group A1 protein acts as a new target of Notch1 signaling and regulates cell proliferation in T leukemia cells.

Authors:  Yang Xi; Yu-Sang Li; He-Bin Tang
Journal:  Mol Cell Biochem       Date:  2012-11-16       Impact factor: 3.396

8.  Self-renewal versus transformation: Fbxw7 deletion leads to stem cell activation and leukemogenesis.

Authors:  John M Perry; Linheng Li
Journal:  Genes Dev       Date:  2008-05-01       Impact factor: 11.361

9.  K-RasG12D-induced T-cell lymphoblastic lymphoma/leukemias harbor Notch1 mutations and are sensitive to gamma-secretase inhibitors.

Authors:  Thomas Kindler; Melanie G Cornejo; Claudia Scholl; Jianing Liu; Dena S Leeman; J Erika Haydu; Stefan Fröhling; Benjamin H Lee; D Gary Gilliland
Journal:  Blood       Date:  2008-07-28       Impact factor: 22.113

10.  The oncogenic roles of Notch1 in astrocytic gliomas in vitro and in vivo.

Authors:  Peng Xu; Mingzhe Qiu; Zhiyong Zhang; Chunsheng Kang; Rongcai Jiang; Zhifan Jia; Guangxiu Wang; Hao Jiang; Peiyu Pu
Journal:  J Neurooncol       Date:  2009-09-22       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.